Patents by Inventor Jeffrey Hewett

Jeffrey Hewett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAGNOSTIC BIOMARKERS FOR FIBROTIC DISORDERS
    Publication number: 20180280476
    Abstract: The present invention provides novel methods of inhibiting fibrosis, as well as methods of treating or inhibiting fibrotic disorders, using BMP9 and/or BMP10 antagonists. The present invention also provides methods of assessing whether a subject has or is at risk of developing a fibrotic disorder by detecting levels of BMP9 and/or BMP10. Further provided are methods of assessing the efficacy of a treatment regimen for treating a fibrotic disorder by detecting and comparing pre-treatment levels of BMP9 and BMP10 with post-treatment levels of BMP9 and BMP10.
    Type: Application
    Filed: June 8, 2018
    Publication date: October 4, 2018
    Applicant: NOVARTIS AG
    Inventors: Alan Buckler, Chao-Min Chen, Chantale T. Guy, Jeffrey Hewett, Chris Xiangyang Lu, Jing Wu
  • Diagnostic BioMarkers for Fibrotic Disorders
    Publication number: 20160228509
    Abstract: The present invention provides novel methods of inhibiting fibrosis, as well as methods of treating or inhibiting fibrotic disorders, using BMP9 and/or BMP10 antagonists. The present invention also provides methods of assessing whether a subject has or is at risk of developing a fibrotic disorder by detecting levels of BMP9 and/or BMP10. Further provided are methods of assessing the efficacy of a treatment regimen for treating a fibrotic disorder by detecting and comparing pre-treatment levels of BMP9 and BMP10 with post-treatment levels of BMP9 and BMP10.
    Type: Application
    Filed: March 28, 2013
    Publication date: August 11, 2016
    Inventors: Alan Buckler, Chao-Min Chen, Chantale T. Guy, Jeffrey Hewett, Chris Lu, Jing Wu
  • Diagnostic BioMarkers for Fibrotic Disorders
    Publication number: 20130209490
    Abstract: The present invention provides novel methods of inhibiting fibrosis, as well as methods of treating or inhibiting fibrotic disorders, using BMP9 and/or BMP10 antagonists. The present invention also provides methods of assessing whether a subject has or is at risk of developing a fibrotic disorder by detecting levels of BMP9 and/or BMP10. Further provided are methods of assessing the efficacy of a treatment regimen for treating a fibrotic disorder by detecting and comparing pre-treatment levels of BMP9 and BMP10 with post-treatment levels of BMP9 and BMP10.
    Type: Application
    Filed: March 28, 2013
    Publication date: August 15, 2013
    Inventors: Alan Buckler, Chao-Min Chen, Chantale T. Guy, Jeffrey Hewett, Chris Lu, Jing Wu
  • DIAGNOSTIC BIOMARKERS FOR FIBROTIC DISORDERS
    Publication number: 20120183543
    Abstract: The present invention provides novel methods of inhibiting fibrosis, as well as methods of treating or inhibiting fibrotic disorders, using BMP9 and/or BMP10 antagonists. The present invention also provides methods of assessing whether a subject has or is at risk of developing a fibrotic disorder by detecting levels of BMP9 and/or BMP10. Further provided are methods of assessing the efficacy of a treatment regimen for treating a fibrotic disorder by detecting and comparing pre-treatment levels of BMP9 and BMP10 with post-treatment levels of BMP9 and BMP10.
    Type: Application
    Filed: May 7, 2010
    Publication date: July 19, 2012
    Applicant: NOVARTIS AG
    Inventors: Alan Buckler, Chao-Min Chen, Chantale T. Guy, Jeffrey Hewett
  • System and method for implementing quality of service fallback using resource reservation protocol
    Patent number: 7733872
    Abstract: A system and method for implementing a Quality of Service (QoS) fallback using Resource Reservation Protocol (RSVP) includes initiating a communication session with a QoS precondition between a first domain and a second domain. It is determined whether the second domain supports the QoS precondition. Intra-domain RSVP is established in the first domain if the second domain does not support the QoS precondition.
    Type: Grant
    Filed: March 29, 2007
    Date of Patent: June 8, 2010
    Assignee: Cisco Technology, Inc.
    Inventors: Jeffrey A. Hewett, Subhasri Dhesikan, John K. Restrick, Jr., Martin W. Wu
  • SYSTEM AND METHOD FOR IMPLEMENTING QUALITY OF SERVICE FALLBACK USING RESOURCE RESERVATION PROTOCOL
    Publication number: 20080240109
    Abstract: A system and method for implementing a Quality of Service (QoS) fallback using Resource Reservation Protocol (RSVP) includes initiating a communication session with a QoS precondition between a first domain and a second domain. It is determined whether the second domain supports the QoS precondition. Intra-domain RSVP is established in the first domain if the second domain does not support the QoS precondition.
    Type: Application
    Filed: March 29, 2007
    Publication date: October 2, 2008
    Inventors: Jeffrey A. Hewett, Subhasri Dhesikan, John K. Restrick, Martin W. Wu